Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Intangibles (2016 - 2019)

Historic Intangibles for Tandem Diabetes Care (TNDM) over the last 8 years, with Q3 2019 value amounting to $885000.0.

  • Tandem Diabetes Care's Intangibles fell 2698.02% to $885000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $885000.0, marking a year-over-year decrease of 2698.02%. This contributed to the annual value of $1.1 million for FY2018, which is 6519.86% down from last year.
  • Tandem Diabetes Care's Intangibles amounted to $885000.0 in Q3 2019, which was down 2698.02% from $967000.0 recorded in Q2 2019.
  • In the past 5 years, Tandem Diabetes Care's Intangibles registered a high of $3.2 million during Q4 2015, and its lowest value of $885000.0 during Q3 2019.
  • In the last 5 years, Tandem Diabetes Care's Intangibles had a median value of $1.7 million in 2017 and averaged $1.9 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Intangibles changed by 0.0% in 2015 and then tumbled by 6519.86% in 2018.
  • Tandem Diabetes Care's Intangibles (Quarter) stood at $3.2 million in 2015, then changed by 0.0% to $3.2 million in 2016, then changed by 0.0% to $3.2 million in 2017, then crashed by 65.2% to $1.1 million in 2018, then dropped by 21.68% to $885000.0 in 2019.
  • Its Intangibles stands at $885000.0 for Q3 2019, versus $967000.0 for Q2 2019 and $1.0 million for Q1 2019.